1921
Volume 84, Issue 6
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

Melioidosis, a bacterial infection caused by , is notoriously difficult to cure despite appropriate antimicrobial therapy and has a mortality rate of up to 40%. We demonstrate that a blood culture positive for taken at the end of the first and/or second week after hospitalization for melioidosis is a strong prognostic factor for death (adjusted odds ratio = 4.2, 95% confidence interval = 2.1–8.7, < 0.001 and adjusted odds ratio = 2.6, 95% confidence interval = 1.1–6.0, = 0.03, respectively). However, repeat cultures of respiratory secretions, urine, throat swabs, or pus/surface swabs provide no prognostic information. This finding highlights the need for follow-up blood cultures in patients with melioidosis.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.2011.10-0618
2011-06-01
2017-11-19
Loading full text...

Full text loading...

/deliver/fulltext/14761645/84/6/858.html?itemId=/content/journals/10.4269/ajtmh.2011.10-0618&mimeType=html&fmt=ahah

References

  1. Limmathurotsakul D, Wongratanacheewin S, Teerawattanasook N, Wongsuvan G, Chaisuksant S, Chetchotisakd P, Chaowagul W, Day NP, Peacock SJ, , 2010. Increasing incidence of human melioidosis in northeast Thailand. Am J Trop Med Hyg 82: 11131117.[Crossref]
  2. Currie BJ, Fisher DA, Howard DM, Burrow JN, Selvanayagam S, Snelling PL, Anstey NM, Mayo MJ, , 2000. The epidemiology of melioidosis in Australia and Papua New Guinea. Acta Trop 74: 121127.[Crossref]
  3. Limmathurotsakul D, Wuthiekanun V, Chierakul W, Cheng AC, Maharjan B, Chaowagul W, White NJ, Day NP, Peacock SJ, , 2005. Role and significance of quantitative urine cultures in diagnosis of melioidosis. J Clin Microbiol 43: 22742276.[Crossref]
  4. Walsh AL, Smith MD, Wuthiekanun V, Suputtamongkol Y, Chaowagul W, Dance DA, Angus B, White NJ, , 1995. Prognostic significance of quantitative bacteremia in septicemic melioidosis. Clin Infect Dis 21: 14981500.[Crossref]
  5. Walsh AL, Wuthiekanun V, , 1996. The laboratory diagnosis of melioidosis. Br J Biomed Sci 53: 249253.
  6. Chaowagul W, Chierakul W, Simpson AJ, Short JM, Stepniewska K, Maharjan B, Rajchanuvong A, Busarawong D, Limmathurotsakul D, Cheng AC, Wuthiekanun V, Newton PN, White NJ, Day NP, Peacock SJ, , 2005. Open-label randomized trial of oral trimethoprim-sulfamethoxazole, doxycycline, and chloramphenicol compared with trimethoprim-sulfamethoxazole and doxycycline for maintenance therapy of melioidosis. Antimicrob Agents Chemother 49: 40204025.[Crossref]
  7. Chaowagul W, Simpson AJ, Suputtamongkol Y, Smith MD, Angus BJ, White NJ, , 1999. A comparison of chloramphenicol, trimethoprim-sulfamethoxazole, and doxycycline with doxycycline alone as maintenance therapy for melioidosis. Clin Infect Dis 29: 375380.[Crossref]
  8. Cheng AC, Limmathurotsakul D, Chierakul W, Getchalarat N, Wuthiekanun V, Stephens DP, Day NP, White NJ, Chaowagul W, Currie BJ, Peacock SJ, , 2007. A randomized controlled trial of granulocyte colony-stimulating factor for the treatment of severe sepsis due to melioidosis in Thailand. Clin Infect Dis 45: 308314.[Crossref]
  9. Chierakul W, Anunnatsiri S, Short JM, Maharjan B, Mootsikapun P, Simpson AJ, Limmathurotsakul D, Cheng AC, Stepniewska K, Newton PN, Chaowagul W, White NJ, Peacock SJ, Day NP, Chetchotisakd P, , 2005. Two randomized controlled trials of ceftazidime alone versus ceftazidime in combination with trimethoprim-sulfamethoxazole for the treatment of severe melioidosis. Clin Infect Dis 41: 11051113.[Crossref]
  10. Wuthiekanun V, Limmathurotsakul D, Wongsuvan G, Chierakul W, Teerawattanasook N, Teparrukkul P, Day NP, Peacock SJ, , 2007. Quantitation of B. pseudomallei in clinical samples. Am J Trop Med Hyg 77: 812813.
  11. Fowler VG, Jr Olsen MK, Corey GR, Woods CW, Cabell CH, Reller LB, Cheng AC, Dudley T, Oddone EZ, , 2003. Clinical identifiers of complicated Staphylococcus aureus bacteremia. Arch Intern Med 163: 20662072.[Crossref]
  12. Baughman RP, Kerr MA, , 2003. Ventilator-associated pneumonia patients who do not reduce bacteria from the lungs have a worse prognosis. J Intensive Care Med 18: 269274.[Crossref]
  13. Simpson AJ, Suputtamongkol Y, Smith MD, Angus BJ, Rajanuwong A, Wuthiekanun V, Howe PA, Walsh AL, Chaowagul W, White NJ, , 1999. Comparison of imipenem and ceftazidime as therapy for severe melioidosis. Clin Infect Dis 29: 381387.[Crossref]
  14. Suputtamongkol Y, Rajchanuwong A, Chaowagul W, Dance DA, Smith MD, Wuthiekanun V, Walsh AL, Pukrittayakamee S, White NJ, , 1994. Ceftazidime vs. amoxicillin/clavulanate in the treatment of severe melioidosis. Clin Infect Dis 19: 846853.[Crossref]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.2011.10-0618
Loading
/content/journals/10.4269/ajtmh.2011.10-0618
Loading

Data & Media loading...

  • Received : 31 Oct 2010
  • Accepted : 06 Feb 2011

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error